Prostate Cancer With Oligometastatic Relapse: Combining Stereotactic Ablative Radiotherapy And Durvalumab, A Randomized Phase Ii Trial (Postcard - Getug-P13).
JOURNAL OF CLINICAL ONCOLOGY(2019)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2019)